Anti-PDGFR-alpha-antistof til anvendelse ved behandling af metastatisk knoglekræft

摘要

The present invention concerns an effective amount of a PDGFR± antagonist for use as a medicament for treating subjects having a bone tumor and also for inhibiting growth of a bone tumor. The PDGFR± antagonist may be an antibody or antibody fragment. In certain embodiments the antagonist can be a bispecific antibody.